|
1
|
Mandita A, Timofte D, Balcangiu-Stroescu
AE, Balan D, Raducu L, Tanasescu MD, Diaconescu A, Dragos D,
Cosconel CI, Stoicescu SM, et al: Treatment of high blood pressure
in patients with chronic renal disease. Rev Chim Buchar.
70:993–995. 2019.
|
|
2
|
Balan DG, Tanasescu MD, Diaconescu A,
Raducu L, Mihai A, Tanase M, Stanescu II, Ionescu D and
Balcangiu-Stroescu AE: Nutritional intervention in patients with
diabetic renal disease a brief presentation. Rev Chim Buchar.
69:4078–4082. 2018.
|
|
3
|
Tanasescu MD, Diaconescu A, Raducu L,
Balan DG, Mihai A, Tanase M, Stanescu II, Ionescu D and
Balcangiu-Stroescu AE: Diabetic nephropathy: Aconcise assessment of
the causes, risk factors and implications in diabetic patients. Rev
Chim Buchar. 69:4018–4021. 2018.
|
|
4
|
Zilisteanu DS: Chronic kidney disease, a
major public health problem. Rom Med J. LX:18–26. 2013.
|
|
5
|
Piccoli GB, Alrukhaimi M, Liu ZH,
Zakharova E and Levin A: World Kidney Day Steering Committee. What
we do and do not know about women and kidney diseases; questions
unanswered and answers unquestioned: Reflection on World Kidney Day
and International Woman's Day. BMC Nephrol. 19(66)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
World Health Organization: Hepatitis C.
https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
Accessed December 15, 2019.
|
|
7
|
Covic A, Iancu L, Apetrei C, Scripcaru D,
Volovat C, Mititiuc I and Covic M: Hepatitis virus infection in
haemodialysis patients from Moldavia. Nephrol Dial Transplant.
14:40–45. 1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vere CC, Streba CT, Streba L and Rogoveanu
I: Statins in the treatment of hepatitis C. Hepat Mon. 12:369–371.
2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Selcuk H, Kanbay M, Korkmaz M, Gur G,
Akcay A, Arslan H, Ozdemir N, Yilmaz U and Boyacioglu S:
Distribution of HCV genotypes in patients with end-stage renal
disease according to type of dialysis treatment. Dig Dis Sci.
51:1420–1425. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Su Y, Norris JL, Zang C, Peng Z and Wang
N: Incidence of hepatitis C virus infection in patients on
hemodialysis: A systematic review and meta-analysis. Hemodial Int.
17:532–541. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kidney Disease; Improving Global Outcomes
(KDIGO) Hepatitis C Work Group. KDIGO 2018 clinical practice
guideline for the prevention, diagnosis, evaluation, and treatment
of hepatitis C in Chronic Kidney Disease. Kidney Int Suppl.
8:91–165. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fissell RB, Bragg-Gresham JL, Woods JD,
Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN,
Akiba T and Young EW: Patterns of hepatitis C prevalence and
seroconversion in hemodialysis units from three continents: The
DOPPS. Kidney Int. 65:2335–2342. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sauné K, Kamar N, Miédougé M, Weclawiak H,
Dubois M, Izopet J and Rostaing L: Decreased prevalence and
incidence of HCV markers in haemodialysis units: A multicentric
French survey. Nephrol Dial Transplant. 26:2309–2316.
2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hmaied F, Ben Mamou M, Saune-Sandres K,
Rostaing L, Slim A, Arrouji Z, Ben Redjeb S and Izopet J: Hepatitis
C virus infection among dialysis patients in Tunisia: Incidence and
molecular evidence for nosocomial transmission. J Med Virol.
78:185–191. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Izopet J, Sandres-Sauné K, Kamar N, Salama
G, Dubois M, Pasquier C and Rostaing L: Incidence of HCV infection
in French hemodialysis units: A prospective study. J Med Virol.
77:70–76. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mbaeyi C and Thompson ND: Hepatitis C
virus screening and management of seroconversions in hemodialysis
facilities. Semin Dial. 26:439–446. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nguyen DB, Gutowski J, Ghiselli M, Cheng
T, Bel Hamdounia S, Suryaprasad A, Xu F, Moulton-Meissner H, Hayden
T, Forbi JC, et al: A large outbreak of hepatitis C virus
infections in a hemodialysis clinic. Infect Control Hosp Epidemiol.
37:125–133. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Savey A, Simon F, Izopet J, Lepoutre A,
Fabry J and Desenclos JC: A large nosocomial outbreak of hepatitis
C virus infections at a hemodialysis center. Infect Control Hosp
Epidemiol. 26:752–760. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Alghamdi AS, Sanai FM, Ismail M, Alghamdi
H, Alswat K, Alqutub A, Altraif I, Shah H and Alfaleh FZ: Saudi
Association for the Study of Liver Diseases and Transplantation.
SASLT practice guidelines: Management of hepatitis C virus
infection. Saudi J Gastroenterol. 18 (Suppl 1):S1–S32.
2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Westbrook RH and Dusheiko G: Natural
history of hepatitis C. J Hepatol. 61 (Suppl 1):S58–S68.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liang TJ, Rehermann B, Seeff LB and
Hoofnagle JH: Pathogenesis, natural history, treatment, and
prevention of hepatitis C. Ann Intern Med. 132:296–305.
2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Thomas DL and Seeff LB: Natural history of
hepatitis C. Clin Liver Dis. 9:383–398. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Han R, Zhou J, François C and Toumi M:
Prevalence of hepatitis C infection among the general population
and high-risk groups in the EU/EEA: A systematic review update. BMC
Infect Dis. 19(655)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim SM and Song IH: Hepatitis C virus
infection in chronic kidney disease: Paradigm shift in management.
Korean J Intern Med. 33:670–678. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Finelli L, Miller JT, Tokars JI, Alter MJ
and Arduino MJ: National surveillance of dialysis-associated
diseases in the United States, 2002. Semin Dial. 18:52–61.
2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Patel PR, Thompson ND, Kallen AJ and
Arduino MJ: Epidemiology, surveillance, and prevention of hepatitis
C virus infections in hemodialysis patients. Am J Kidney Dis.
56:371–378. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Barril G and Traver JA: Decrease in the
hepatitis C virus (HCV) prevalence in hemodialysis patients in Spa
in: Effect of time, initiating HCV prevalence studies and adoption
of isolation measures. Antiviral Res. 60:129–134. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Taskapan H, Oymak O, Dogukan A and Utas C:
Patient to patient transmission of hepatitis C virus in
hemodialysis units. Clin Nephrol. 55:477–481. 2001.PubMed/NCBI
|
|
29
|
Caragea DC, Mihailovici AR, Streba CT,
Schenker M, Ungureanu B, Caragea IN, Popa R, Obleaga C and Vere CC:
Hepatitis C infection in hemodialysis patients. Curr Health Sci J.
44:107–112. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ranjith-Kumar CT and Kao CC: Biochemical
activities of the HCV NS5B RNA-dependent RNA polymerase. In:
Hepatitis C Viruses: Genomes and Molecular Biology. Tan SL (ed).
Horizon Bioscience, Norfolk, 2006.
|
|
31
|
Lindenbach BD, Thiel HJ and Rice CM:
Flaviviridae: The Viruses and their Replication. In: Fields
Virology. 5th edition. Knipe DM and Howley PM (eds).
Lippincott-Raven Publishers, Philadelphia, pp1101-1152, 2007.
|
|
32
|
Simmonds P, Bukh J, Combet C, Deléage G,
Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens
G, et al: Consensus proposals for a unified system of nomenclature
of hepatitis C virus genotypes. Hepatology. 42:962–973.
2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lauer GM and Walker BD: Hepatitis C virus
infection. N Engl J Med. 345:41–52. 2001.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wallach J: Hepatobiliary and pancreatic
disorders. In: Interpreting Diagnostic Tests. 7th edition. Wallach
J (ed). Medical Sciences Publishing House, Romania, pp316-323,
2001.
|
|
35
|
Gronowski AM: Screening and diagnosis of
congenital infections. In: Handbook of Clinical Laboratory Testing
During Pregnancy. Gronowski AM (ed). Totowa, NJ, p257, 2004.
|
|
36
|
Martin P, Jadoul M and Pol S: HCV in the
hemodialysis population: Treat now or later? J Viral Hepat.
27:233–234. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fabrizi F, Messa P and Martin P: Recent
advances on hepatitis C virus in dialysis population. Kidney Blood
Press Res. 39:260–271. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kalantar-Zadeh K, McAllister CJ and Miller
LG: Clinical characteristics and mortality in hepatitis C-positive
haemodialysis patients: A population based study. Nephrol Dial
Transplant. 20:1662–1669. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Balcangiu-Stroescu AE, Tanasescu MD,
Diaconescu A, Raducu L, Constantin AM, Balan DG, Tarmure V and
Ionescu D: Cardiovascular comorbidities, inflammation and serum
albumin levels in a group of hemodialysis patients. Rev Chim
Buchar. 69:926–929. 2018.
|
|
40
|
Diaconu C: Treatment of diabetes in
patients with heart failure. In: Proceedings of the 3rd
International Conference on Interdisciplinary Management of
Diabetes Mellitus and its Complications -Diabetes mellitus as
cardiovascular disease. INTERDIAB, Bucharest, pp170-177, 2017.
|
|
41
|
Gordon CE, Berenguer MC, Doss W, Fabrizi
F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, et al:
Prevention, diagnosis, evaluation, and treatment of Hepatitis C
virus infection in chronic kidney disease: Synopsis of the kidney
disease: Improving Global Outcomes 2018 Clinical Practice
Guideline. Ann Intern Med. 171:496–504. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Curescu M, Golea O and Brinzan F:
Mihăilescu M and Cotospan E: Prevalence of anti-HCV antibodies in
patients undergoing hemodialysis and in medical staff in
hemodialysis centers. Rom J Infect Dis. X:145–148. 2007.
|
|
43
|
Jadoul M, Berenguer MC, Doss W, Fabrizi F,
Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, et al:
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline:
Welcoming advances in evaluation and management. Kidney Int.
94:663–673. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gheorghe G, Stoian AP, Găman MA, Socea B,
Neagu TP, Stănescu AM, Bratu OG, Mischianu DL, Suceveanu AI and
Diaconu CC: The benefits and risks of antioxidant treatment in
liver diseases. Rev Chim Buchar. 70:651–655. 2019.
|
|
45
|
Suceveanu AI, Pantea Stoian A, Mazilu L,
Voinea F, Hainăroșie R, Diaconu CC, Pițuru S, Nițipir C, Badiu DC,
Ceaușu I, et al: Interferon-free therapy is not a trigger for
hepatocellular carcinoma in patients with chronic infection with
hepatitis C virus. Farmacia. 66:904–908. 2018.
|
|
46
|
Fierbinteanu-Braticevici C, Papacocea R,
Tribus L and Cristian B: Role of 13C methacetin breath test for non
invasive staging of liver fibrosis in patients with chronic
hepatitis C. Indian J Med Res. 140:123–129. 2014.PubMed/NCBI
|
|
47
|
Lothar T (ed): Hepatitis C. In: Clinical
Laboratory Diagnostics - Use and Assessment of Clinical Laboratory
Results. 1st edition. TH-Books, Germany, pp1273-1276, 1998.
|
|
48
|
Nguyen DB, Bixler D and Patel PR:
Transmission of hepatitis C virus in the dialysis setting and
strategies for its prevention. Semin Dial. 32:127–134.
2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
https://www.asn-online.org/ntds/resources/20190509-NCHHSTP_NTDS-HCV_Subcommittee_Algorithm.pdf.
Accessed December 17, 2019.
|
|
50
|
Marwaha N and Sachdev S: Current testing
strategies for hepatitis C virus infection in blood donors and the
way forward. World J Gastroenterol. 20:2948–2954. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Thompson ND, Novak RT, White-Comstock MB,
Xia GL, Ganova-Raeva L, Ramach S, Khudyakov YE, Bialek SR and
Williams IT: Patient-to-patient hepatitis C virus transmissions
associated with infection control breaches in a hemodialysis unit.
J Nephrol Therapeutics. 10(2)2012.
|
|
52
|
Aho-Glélé LS, Giraudon H, Astruc K,
Soltani Z, Lefebvre A, Pothier P, Bour JB and Manoha C:
Investigation of a case of genotype 5a hepatitis C virus
transmission in a French hemodialysis unit using epidemiologic data
and deep sequencing. Infect Control Hosp Epidemiol. 37:134–139.
2016.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Thompson ND, Novak RT, Datta D, Cotter S,
Arduino MJ, Patel PR, Williams IT and Bialek SR: Hepatitis C virus
transmission in hemodialysis units: Importance of infection control
practices and aseptic technique. Infect Control Hosp Epidemiol.
30:900–903. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
54
|
Fabrizi F and Messa P: Transmission of
hepatitis C virus in dialysis units: A systematic review of reports
on outbreaks. Int J Artif Organs. 38:471–480. 2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
No authors listed. Recommendations for
preventing transmission of infections among chronic hemodialysis
patients. MMWR Recomm Rep. 50:1–43. 2001.PubMed/NCBI
|
|
56
|
Bianco A, Bova F, Nobile CG, Pileggi C and
Pavia M: Collaborative Working Group. Healthcare workers and
prevention of hepatitis C virus transmission: Exploring knowledge,
attitudes and evidence-based practices in hemodialysis units in
Italy. BMC Infect Dis. 13(76)2013.
|
|
57
|
Centers for Disease Control and
Prevention: Healthcare-associated hepatitis B and C outbreaks
reported to the Centers for Disease Control and Prevention
2008-2015. https://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm.
Accessed July 27, 2018.
|
|
58
|
The Centers for Disease Control and
Prevention. CDC urging dialysis providers and facilities to assess
and improve infection control practices to stop hepatitis C virus
transmission in patients undergoing hemodialysis. Am J Transplant.
16:1633–1634. 2016.
|
|
59
|
Labriola L and Jadoul M: The decades-long
fight against HBV transmission to dialysis patients: Slow but
definite progress. Nephrol Dial Transplant. 25:2047–2049.
2010.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Jadoul M: Should hemodialysis patients
with hepatitis C virus antibodies be isolated? Semin Dial. 8:1–3.
1995.
|
|
61
|
Soliman AR, Momtaz Abd Elaziz M and El
Lawindi MI: Evaluation of an isolation program of hepatitis C virus
infected hemodialysis patients in some hemodialysis centers in
Egypt. ISRN Nephrol: Oct 31, 2013 (Epub ahead or print). doi:
10.5402/2013/395467.
|
|
62
|
Agarwal SK: Hemodialysis of patients with
HCV infection: Isolation has a definite role. Nephron Clin Pract.
117:c328–c332. 2011.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Jadoul M, Cornu C and van Ypersele de
Strihou C: The Universitaires Cliniques St-Luc (UCL) Collaborative
Group. Universal precautions prevent hepatitis C virus
transmission: A 54 month follow-up of the Belgian Multicenter
Study. Kidney Int. 53:1022–1025. 1998.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Petrosillo N, Gilli P, Serraino D, Dentico
P, Mele A, Ragni P, Puro V, Casalino C and Ippolito G: Prevalence
of infected patients and understaffing have a role in hepatitis C
virus transmission in dialysis. Am J Kidney Dis. 37:1004–1010.
2001.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Mactier R, Davies S, Dudley C, Harden P,
Jones C, Kanagasundaram S, Lewington A, Richardson D, Taal M,
Andrews P, et al: Summary of the 5th edition of the Renal
Association Clinical Practice Guidelines (2009-2012). Nephron Clin
Pract. 118 (Suppl 1):c27–c70. 2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
European Best Practice Guidelines Expert
Group on Hemodialysis European Renal Association. Section VI.
Haemodialysis-associated infection. Nephrol Dial Transplant. 17
(Suppl 7):72–87. 2002.PubMed/NCBI
|
|
67
|
Garthwaite E, Reddy V, Douthwaite S, Lines
S, Tyerman K and Eccles J: Clinical practice guideline management
of blood borne viruses within the haemodialysis unit. BMC Nephrol.
20(388)2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Regulament din 23 Decembrie 2004.
http://legislatie.just.ro/Public/DetaliiDocumentAfis/61116.
Accessed December 18, 2019.
|
|
69
|
Recommendations for Preventing
Transmission of Infections Among Chronic Hemodialysis Patients.
MMWR Recomm Rep 50: 1-43, 2001. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5005a1.htm.
Accessed December 18, 2019.
|
|
70
|
Constancio NS, Gomes Ferraz ML, Tzanno C,
Martins B, Campos Kraychete A, Bitencourt PL and Mazza do
Nascimento M: Hepatitis C in hemodialysis units: Diagnosis and
therapeutic approach. J Bras Nefrol 41: 539-549 (In English,
Portuguese).
|
|
71
|
dos Santos JP, Loureiro A, Cendoroglo Neto
M and Pereira BJ: Impact of dialysis room and reuse strategies on
the incidence of hepatitis C virus infection in haemodialysis
units. Nephrol Dial Transplant. 11:2017–2022. 1996.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Alashek WA, McIntyre CW and Taal MW:
Hepatitis B and C infection in haemodialysis patients in Libya:
Prevalence, incidence and risk factors. BMC Infect Dis.
12(265)2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
National Kidney Foundation: Hepatitis C
management and hemodialysis. https://www.kidney.org/professionals/KDOQI/12-10-1601.
Accessed December 18, 2019.
|
